Photo‐Activated Oxidative Stress Amplifier: A Strategy for Targeting Glutathione Metabolism and Enhancing ROS‐Mediated Therapy in Triple‐Negative Breast Cancer Treatment
Small · 2024-12 · 20 (51)
DOI: 10.1002/smll.202403861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 03.08.2024. Verfasst von Li Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Liquid-Solid Structural Evolution & Processing of Materials (Ministry of Education), School of Materials Science and Engineering, Shandong University…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Oxidative Stress, Glutathione, Reactive Oxygen Species. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Amplifying oxidative stress within tumor cells can effectively inhibit the growth and metastasis of triple‐negative breast cancer (TNBC). Therefore, the development of innovative nanomedicines that can effectively disrupt the redox balance represents a promising yet challenging therapeutic strategy for TNBC. In this study, an oxidative stress amplifier, denoted as PBCH, comprising PdAg mesoporous nanozyme and a CaP mineralized layer, loaded with GSH inhibitor L‐buthionine sulfoximine (BSO), and further surface‐modified with hyaluronic acid that can target CD44, is introduced. In the acidic tumor microenvironment, Ca 2+ is initially released, thereby leading to mitochondrial dysfunction and eventually triggering apoptosis. Additionally, BSO suppresses the synthesis of intracellular reduced GSH and further amplifies the level of oxidative stress in cancer cells. Furthermore, PdAg nanozyme can be activated by near‐infrared light to induce photothermal and photodynamic effects, causing a burst of ROS and simultaneously promoting cell apoptosis via provoking immunogenic cell death. The high‐performance therapeutic effects of PBCH, based on the synergistic effect of aforementioned multiple oxidative damage and photothermal ablation, are validated in TNBC cells and animal models, declaring its potential as a safe and effective anti‐tumor agent. The proposed approach offers new perspectives for precise and efficient treatment of TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liquid-Solid Structural Evolution & Processing of Materials (Ministry of Education), School of Materials Science and Engineering, Shandong University, Jinan, Shandong, 250061, China.
- The Second Hospital of Shandong University, Jinan, Shandong, 250033, China.
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.
- Shandong Provincial Key Laboratory of Innovation Technology in Laboratory Medicine, Jinan, Shandong, 250033, China.
- Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory, Jinan, Shandong, 250033, China.
ORCID-Profile: Yanyan Jiang
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zhao, L., Tong, Y., Yin, J., Li, H., Du, L., Li, J., & Jiang, Y. (2024). Photo‐Activated Oxidative Stress Amplifier: A Strategy for Targeting Glutathione Metabolism and Enhancing ROS‐Mediated Therapy in Triple‐Negative Breast Cancer Treatment. Small, 20(51). https://doi.org/10.1002/smll.202403861
Vancouver
Zhao L, Tong Y, Yin J, Li H, Du L, Li J, et al. Photo‐Activated Oxidative Stress Amplifier: A Strategy for Targeting Glutathione Metabolism and Enhancing ROS‐Mediated Therapy in Triple‐Negative Breast Cancer Treatment. Small. 2024;20(51). doi:10.1002/smll.202403861
BibTeX
@article{Zhao2024,
author = {Zhao, Li and Tong, Yao and Yin, Jiawei and Li, Hui and Du, Lutao and Li, Juan and Jiang, Yanyan},
title = {Photo‐Activated Oxidative Stress Amplifier: A Strategy for Targeting Glutathione Metabolism and Enhancing ROS‐Mediated Therapy in Triple‐Negative Breast Cancer Treatment},
journal = {Small},
year = {2024},
volume = {20},
number = {51},
doi = {10.1002/smll.202403861}
}
EUVIMED